Two regulated tracks.
One supply engine.
Zero registered competitors — globally.
Persea Vitalis Inc. is Canada's first NPN-ready platform — a circular-bioeconomy, double-waste-reduction, climate-aligned clean-tech venture converting a single under-valued organic input into regulated products spanning wellness, food-preservation, and active-packaging. Two distinct tracks advancing through Health Canada and PMRA pathways, supported by a shared circular supply chain at near-marginal incremental cost.
Complete technical package — regulatory strategy, TRL scoring, supply chain architecture, financial model — available to verified partners under NDA.
The Platform
Two uncontested markets. One platform.
Each track operates under a separate regulatory framework, sequencing rapid food-grade approvals ahead of a defensible biopesticide moat — while sharing a common supply chain that reduces infrastructure cost and accelerates both timelines simultaneously.
Natural health product. No registered predecessor globally. No published clinical precedent. First-mover position fully documented.
Biochemical biopesticide. No registered product of this class in PMRA or US-EPA registries. Reduced-risk pathway, harmonised with US-EPA biopesticide designation. The regulatory moat no fast-follower can shortcut.
A cold-chain, batch-segregated waste-diversion and traceability system supplying specification-controlled feedstock to both product tracks — one supply line serving all regulated outputs at marginal incremental cost.
Why Now
A sector under structural pressure. Two markets with no incumbent.
Canada loses an estimated $58 billion in avoidable food waste annually, with fruit and vegetables accounting for approximately 45%. Fungicide resistance is widening. Maximum residue limits are tightening. Retailer residue-reduction programmes actively reward food-derived, residue-free inputs — and the biofungicide market reflects it.
Fruit & vegetables ≈ 45%
→ $3.93B by 2035 · 8.6% CAGR
PMRA · US-EPA · Health Canada NHPD · PubMed · ClinicalTrials.gov
Search scope: Health Canada NHPD, PMRA registry, US-EPA biopesticide list, PubMed, ClinicalTrials.gov, Cochrane, EFSA Journal. June 2026.
Who We Work With
Three entry points. One platform.
University and institutional research partners contributing to regulatory dossier development. Active relationships: Seneca SCILS · University of Guelph. Structures include Mitacs Accelerate, joint research agreements, and CRO subcontracts.
Research Enquiry →Ontario food-sector processors and commercial partners exploring SeedCircle waste-diversion agreements and commercial product partnerships ahead of regulated product launch.
Commercial Enquiry →First-mover in two uncontested regulated markets. No equity raised to date. Non-dilutive runway: Bioenterprise GOAH · NRC IRAP · Mitacs · SR&ED · OAFRI · Natural Products Canada · FedDev Ontario. Investor brief under NDA.
Investor Access →Credentials & Status
Built on documented evidence. Registered, funded, and in motion.
The Founder
Ermiyas Abebayehu Kassa
Founder & CEO · Persea Vitalis Inc.
BSc Agriculture · MSc Green Economy (Bournemouth, UK) · GradCert Business Analytics (Seneca). Twenty years of applied agri-value-chain science underpin the platform.
FAO (UN) · World Vision International. USD $30M+ portfolio across 12 countries on 4 continents — grant-compliance and results-based management.
Led regulatory and product strategy across four Health Canada pathways — NPN, food additives, food-contact materials, and biochemical plant-health registration — sequencing rapid food-grade approvals ahead of a defensible biopesticide moat. Advanced a postharvest portfolio (bio-antifungal, anti-browning, biodegradable active-film) and a nutraceutical track to pilot readiness. Authored all investor, regulatory, and partner-facing artefacts — built on peer-reviewed evidence, positioning Persea Vitalis as an evidence-driven, climate-aligned clean-technology platform.